Skip to content

Status report on the use of megadose nicotinic acid in alcoholics

The current status of niacin research in alcoholics was reviewed. A five-year field trial with nicotinic acid strongly suggested great potential for benefit in alcoholics. The next logical step was a confirmatory blind crossover study. Such a study was deemed even more important because it represented the kind of evidence acceptable to the scientific community, the author writes.

Three obstacles still stood in the way of such a study. The current literature and observations in previous studies allowed the development of a theoretical approach to the effect of nicotinic acid at the point of 5- OH-tryptamine metabolism. A set of clinical criteria was developed that had been tested in a previous study based on the tryptamine metabolic cycle.

A satisfactory test form of nicotinic acid was found in the form of a timed release that eliminated the telltale histamine start symptoms, allowing identical placebo development. Once these significant barriers were removed, a blind crossover study was conducted in a study population selected to demonstrate maximum effect.

Status Report Concerning the Use of Megadose Nicotinic Acid in Alcoholics.

Powered by BetterDocs

Close Popup

Bye bye booze needs a few cookies, too.

However, we try only to activate as few as possible technically necessary cookies so that your visit to this site cannot be tracked as far as possible by third parties. We do not share any information about your visit with anyone.

But even we we do need a few - e.g. to display this legal notice or to care for that you do not have to log in again for each page or see this popup again for each page.

As soon as you click on an external link or video, cookies may be set by the operators of these sites, which we cannot influence. Learn more on our privacy page.

Close Popup